BISPHOSPHONATES IN THE TREATMENT OF OSTEOPOROSIS. EFFICACY AND SAFETY OF IBANDRONATE
Osteoporosis (OP) - is a common noncommunicable disease with such threatening complication as bone fractures leading to disability, a significant reduction in quality of life, and high mortality. The article presents data from international clinical studies on the efficacy and tolerability of third-generation nitrogen-containing bisphosphonate - Ibandronate (Bonviva) - in female patients with OP. A modern integrated approach to the treatment of OP, both pharmacological and non-drug methods of therapy, as well as ways to assessment of the clinical efficacy of drug therapy of OP.